HCW Biologics Inc. (HCWB) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 2.03M |
| Enterprise Value | 6.89M |
| P/E Ratio | -0.09 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0.24 |
| Price/Book Ratio | 0.28 |
| Enterprise/Revenue | 1.05 |
| Enterprise/EBITDA | -11.46 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.25 |
| Operating Margin | -0.98 |
| Return On Assets | -0.06 |
| Return On Equity | -1.02 |
| Revenue | 54,232 |
| Revenue/Share | 18.86 |
| Gross Profit | 10,846 |
| EBITDA | -5.67M |
| Net Income | -7.96M |
| Diluted EPS | -63.78 |
| Total Cash | 1.23M |
| Total Cash/Share | 3.51 |
| Total Debt | 6.58M |
| Total Debt/Equity | 1.14 |
| Current Ratio | 0.09 |
| Book Value Per Share | 16.48 |
| 52-Week Change | -82.45 |
| 52-Week High | 44.1 |
| 52-Week Low | 1.5 |
| Moving Average 50 Days | 6.83 |
| Moving Average 200 Days | 9.65 |
| Average Volume | 2.14M |
| Shares Outstanding | 347,641 |
| % Held by Institutions | 21.44 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:6 |
| Last Split Date | June 30, 2026 |